Upgrade to SI Premium - Free Trial

uniQure (QURE)

38.97 -0.46 (1.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

uniQure to Announce Second Quarter 2026 Financial Results July 22, 2026 7:05 AM - Globe NewsWire uniQure (QURE) call put ratio 1.2 calls to 1 put July 22, 2026 3:58 AM - StreetInsider Form SCHEDULE 13G/A uniQure N.V. Filed by: Aberdeen Group plc July 20, 2026 9:37 AM - SEC Filing Form SCHEDULE 13G uniQure N.V. Filed by: JPMORGAN CHASE & CO July 16, 2026 2:09 PM - SEC Filing Form 4 uniQure N.V. For: Jul 02 Filed by: Kapusta Matthew C July 7, 2026 4:48 PM - SEC Filing Form 4 uniQure N.V. For: Jun 30 Filed by: Abi-Saab Walid July 2, 2026 5:00 PM - SEC Filing Form 4 uniQure N.V. For: Jun 30 Filed by: Kaye Jack July 2, 2026 4:55 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kapusta Matthew C July 2, 2026 4:00 PM - SEC Filing Form 4 uniQure N.V. For: Jun 26 Filed by: Abi-Saab Walid June 30, 2026 5:07 PM - SEC Filing Form 144 uniQure N.V. Filed by: Abi-Saab Walid June 30, 2026 4:01 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kaye Jack June 30, 2026 4:00 PM - SEC Filing H.C. Wainwright Maintains uniQure BV (QURE) at Buy (correction) June 29, 2026 6:03 AM - StreetInsider Form 4 uniQure N.V. For: Jun 24 Filed by: Kapusta Matthew C June 26, 2026 5:15 PM - SEC Filing Form 144 uniQure N.V. Filed by: Abi-Saab Walid June 26, 2026 4:06 PM - SEC Filing uniQure closes $259 million public offering at $45.50 per share June 25, 2026 4:10 PM - StreetInsider uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares June 25, 2026 4:10 PM - Globe NewsWire Form 144 uniQure N.V. Filed by: Kapusta Matthew C June 25, 2026 4:00 PM - SEC Filing uniQure BV (QURE) PT Raised to $68 at Mizuho June 25, 2026 6:33 AM - StreetInsider Form 8-K uniQure N.V. For: Jun 23 June 24, 2026 4:54 PM - SEC Filing Form 424B5 uniQure N.V. June 24, 2026 4:53 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kapusta Matthew C June 24, 2026 4:01 PM - SEC Filing uniQure prices $225 million public offering at $45.50 per share June 23, 2026 9:14 PM - StreetInsider uniQure Announces Pricing of Upsized $225 Million Public Offering June 23, 2026 9:13 PM - Globe NewsWire Form 424B5 uniQure N.V. June 22, 2026 5:09 PM - SEC Filing uniQure launches $150 million public share offering June 22, 2026 4:01 PM - StreetInsider uniQure Announces $150 Million Proposed Public Offering June 22, 2026 4:01 PM - Globe NewsWire Form 4 uniQure N.V. For: Jun 17 Filed by: Kapusta Matthew C June 22, 2026 8:31 AM - SEC Filing Form 4 uniQure N.V. For: Jun 17 Filed by: Balachandran Madhavan June 22, 2026 8:05 AM - SEC Filing Barclays Upgrades uniQure BV (QURE) to Overweight June 22, 2026 7:55 AM - StreetInsider Form 4 uniQure N.V. For: Jun 17 Filed by: Kaye Jack June 22, 2026 7:54 AM - SEC Filing Form 8-K uniQure N.V. For: Jun 19 June 22, 2026 6:50 AM - SEC Filing uniQure reports early data from AMT-260 epilepsy gene therapy trial June 19, 2026 7:05 AM - StreetInsider uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy June 19, 2026 7:05 AM - Globe NewsWire Form 144 uniQure N.V. Filed by: Kapusta Matthew C June 18, 2026 5:57 PM - SEC Filing uniQure BV (QURE) PT Raised to $65 at RBC Capital June 18, 2026 7:42 AM - StreetInsider Barclays Upgrades uniQure BV (QURE) to Overweight Following 78% Gain Yesterday June 18, 2026 7:10 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on uniQure BV (QURE) June 18, 2026 6:48 AM - StreetInsider uniQure BV (QURE) PT Raised to $70 at Leerink June 18, 2026 6:43 AM - StreetInsider Form 144 uniQure N.V. Filed by: Kapusta Matthew C June 17, 2026 8:07 PM - SEC Filing Form 4 uniQure N.V. For: Jun 15 Filed by: Balachandran Madhavan June 17, 2026 5:02 PM - SEC Filing Form 4 uniQure N.V. For: Jun 15 Filed by: Potts Jeannette June 17, 2026 4:57 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kaye Jack June 17, 2026 4:34 PM - SEC Filing Form 144 uniQure N.V. Filed by: Balachandran Madhavan June 17, 2026 4:05 PM - SEC Filing Goldman Sachs on uniQure BV (QURE): 'we now expect a US approval in 2Q27 (vs. 2030 prior, assuming priority review...' June 17, 2026 1:29 PM - StreetInsider Mizuho on uniQure BV (QURE): 'expressed confidence the overall signal — namely the slowing of disease progression — should remain directionally consistent' June 17, 2026 1:27 PM - StreetInsider Cantor Fitzgerald Upgrades uniQure BV (QURE) to Overweight June 17, 2026 11:49 AM - StreetInsider Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers June 17, 2026 10:38 AM - StreetInsider uniQure BV (QURE) PT Raised to $71 at Stifel June 17, 2026 9:31 AM - StreetInsider Barclays Comments on uniQure BV (QURE) Amid 66% Gain: 'a major positive' June 17, 2026 9:11 AM - StreetInsider uniQure (QURE) to resume trading at 7:35 a.m. June 17, 2026 7:22 AM - StreetInsider ClearPoint Neuro stock surges on peer's FDA approval plan June 17, 2026 7:21 AM - StreetInsider Form 8-K uniQure N.V. For: Jun 17 June 17, 2026 7:11 AM - SEC Filing uniQure plans BLA submission for Huntington's therapy in Q3 2026 June 17, 2026 7:06 AM - StreetInsider uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease June 17, 2026 7:05 AM - Globe NewsWire Form 8-K uniQure N.V. For: Jun 10 June 15, 2026 4:31 PM - SEC Filing Form 144 uniQure N.V. Filed by: Potts Jeannette June 15, 2026 4:00 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Meek David D. June 12, 2026 6:13 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Gut Robert June 12, 2026 6:04 PM - SEC Filing Form 4 uniQure N.V. For: Jun 11 Filed by: O'Keefe Kylie June 12, 2026 5:55 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Springhorn Jeremy P. June 12, 2026 5:46 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: POST LEONARD E June 12, 2026 5:39 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Kaye Jack June 12, 2026 5:30 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Jacques Rachelle Suzanne June 12, 2026 5:16 PM - SEC Filing Form 4 uniQure N.V. For: Jun 10 Filed by: Balachandran Madhavan June 12, 2026 5:09 PM - SEC Filing Form 144 uniQure N.V. Filed by: O'Keefe Kylie June 11, 2026 4:39 PM - SEC Filing Form 144 uniQure N.V. Filed by: Balachandran Madhavan June 11, 2026 4:30 PM - SEC Filing Form 144 uniQure N.V. Filed by: Gut Robert June 11, 2026 4:25 PM - SEC Filing Form 144 uniQure N.V. Filed by: Springhorn Jeremy P. June 11, 2026 4:23 PM - SEC Filing Form 144 uniQure N.V. Filed by: Jacques Rachelle Suzanne June 11, 2026 4:22 PM - SEC Filing Form 144 uniQure N.V. Filed by: POST LEONARD E June 11, 2026 4:20 PM - SEC Filing Form 144 uniQure N.V. Filed by: Meek David D. June 11, 2026 4:19 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kaye Jack June 11, 2026 4:18 PM - SEC Filing Form 144 uniQure N.V. Filed by: Gut Robert June 10, 2026 4:00 PM - SEC Filing Form 4 uniQure N.V. For: Jun 03 Filed by: Kaye Jack June 5, 2026 4:43 PM - SEC Filing Form 144 uniQure N.V. Filed by: Kaye Jack June 3, 2026 3:58 PM - SEC Filing Form SCHEDULE 13G/A uniQure N.V. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:40 AM - SEC Filing Form 4 uniQure N.V. For: May 08 Filed by: Abi-Saab Walid May 12, 2026 4:55 PM - SEC Filing FDA Commissioner Marty Makary is resigning - Politico reporter on X May 12, 2026 12:49 PM - StreetInsider Form SCHEDULE 13G uniQure N.V. Filed by: STATE STREET CORP May 12, 2026 12:14 PM - SEC Filing Form 144 uniQure N.V. Filed by: Abi-Saab Walid May 8, 2026 4:01 PM - SEC Filing uniQure BV (QURE) PT Lowered to $50 at H.C. Wainwright May 7, 2026 7:44 AM - StreetInsider Form SCHEDULE 13G/A uniQure N.V. Filed by: FMR LLC May 6, 2026 11:41 AM - SEC Filing uniQure BV (QURE) PT Raised to $14 at Goldman Sachs May 6, 2026 6:44 AM - StreetInsider uniQure (QURE) Tops Q1 EPS by 2c May 5, 2026 7:28 AM - StreetInsider Form 10-Q uniQure N.V. For: Mar 31 May 5, 2026 7:16 AM - SEC Filing Form 8-K uniQure N.V. For: May 05 May 5, 2026 7:07 AM - SEC Filing uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates May 5, 2026 7:05 AM - Globe NewsWire Form SCHEDULE 13G/A uniQure N.V. Filed by: Aberdeen Group plc April 30, 2026 10:20 AM - SEC Filing Form 8-K uniQure N.V. For: Apr 30 April 30, 2026 7:07 AM - SEC Filing uniQure plans UK regulatory filing for Huntington's disease gene therapy April 30, 2026 7:06 AM - StreetInsider uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease April 30, 2026 7:05 AM - Globe NewsWire uniQure to Announce First Quarter 2026 Financial Results April 28, 2026 7:05 AM - Globe NewsWire Form ARS uniQure N.V. For: Dec 31 April 27, 2026 7:03 AM - SEC Filing Form DEFA14A uniQure N.V. April 27, 2026 7:01 AM - SEC Filing Form DEF 14A uniQure N.V. For: Jun 10 April 27, 2026 7:00 AM - SEC Filing Full Article List